# OnCo record non-muscle-invasive-bladder-cancer (cancer). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/cancers/non-muscle-invasive-bladder-cancer/>
  a schema:MedicalCondition ;
  onco:kind "cancer" ;
  schema:identifier "non-muscle-invasive-bladder-cancer" ;
  schema:name "Non-muscle-invasive bladder cancer"@en ;
  schema:alternateName "NMIBC"@en, "Superficial bladder cancer"@en, "Ta, T1 and carcinoma in situ of the bladder"@en ;
  schema:description "Most bladder cancers are found while still confined to the lining. They are scraped out through the urethra and, when higher risk, treated with BCG instilled into the bladder; the challenge is the frequent recurrences and the patients whose tumours stop responding to BCG."@en ;
  schema:url <https://onco.cc/cancers/non-muscle-invasive-bladder-cancer/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Bladder_cancer> ;
  schema:citation <https://en.wikipedia.org/wiki/Bladder_cancer> ;
  onco:tag "subtype-page" ;
  onco:related <https://onco.cc/cancers/muscle-invasive-bladder-cancer/> ;
  onco:trials <https://onco.cc/trials/keynote-057/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-keynote-057-lancet-oncol-2021/>, <https://onco.cc/key-papers/paper-nadofaragene-firadenovec-lancet-oncol-2021/>, <https://onco.cc/key-papers/paper-sylvester-eortc-risk-tables-eur-urol-2006/>, <https://onco.cc/key-papers/paper-eau-nmibc-guideline-eur-urol-2022/> ;
  onco:pipeline <https://onco.cc/drugs/tar-200/>, <https://onco.cc/drugs/cretostimogene/> ;
  onco:standardOfCare <https://onco.cc/cancers/urothelial/>, <https://onco.cc/drugs/mitomycin/>, <https://onco.cc/drugs/gemcitabine/>, <https://onco.cc/technologies/bcg-and-intravesical-therapy/>, <https://onco.cc/terms/cystectomy/>, <https://onco.cc/drugs/pembrolizumab/>, <https://onco.cc/drugs/nadofaragene-firadenovec/>, <https://onco.cc/drugs/nogapendekin-alfa/>, <https://onco.cc/drugs/tar-200/>, <https://onco.cc/drugs/cretostimogene/> .